A detailed history of Bryn Mawr Trust CO transactions in Bio Techne Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 4,651 shares of TECH stock, worth $339,662. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,651
Previous 2,995 55.29%
Holding current value
$339,662
Previous $214,000 73.36%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

BUY
$70.96 - $82.35 $117,509 - $136,371
1,656 Added 55.29%
4,651 $371,000
Q2 2024

Aug 08, 2024

SELL
$62.12 - $84.15 $10,871 - $14,726
-175 Reduced 5.52%
2,995 $214,000
Q1 2024

May 14, 2024

SELL
$65.98 - $77.09 $25,402 - $29,679
-385 Reduced 10.83%
3,170 $223,000
Q3 2023

Nov 15, 2023

SELL
$67.52 - $89.42 $7,427 - $9,836
-110 Reduced 3.0%
3,555 $241,000
Q2 2023

Aug 11, 2023

SELL
$73.76 - $85.98 $8,113 - $9,457
-110 Reduced 2.91%
3,665 $300,000
Q1 2023

May 15, 2023

SELL
$71.62 - $86.62 $54,789 - $66,264
-765 Reduced 16.85%
3,775 $280,000
Q4 2022

Feb 10, 2023

BUY
$80.67 - $352.29 $268,631 - $1.17 Million
3,330 Added 275.21%
4,540 $376,000
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $24,015 - $33,307
-85 Reduced 6.56%
1,210 $343,000
Q2 2022

Aug 11, 2022

SELL
$322.67 - $449.65 $6,453 - $8,993
-20 Reduced 1.52%
1,295 $449,000
Q1 2022

May 16, 2022

SELL
$353.85 - $487.79 $56,616 - $78,046
-160 Reduced 10.85%
1,315 $570,000
Q4 2021

Feb 10, 2022

SELL
$456.15 - $525.06 $20,526 - $23,627
-45 Reduced 2.96%
1,475 $763,000
Q3 2021

Oct 26, 2021

SELL
$444.87 - $538.88 $22,243 - $26,944
-50 Reduced 3.18%
1,520 $737,000
Q2 2021

Jul 29, 2021

SELL
$387.35 - $450.26 $7,747 - $9,005
-20 Reduced 1.26%
1,570 $707,000
Q1 2021

Apr 23, 2021

SELL
$314.62 - $411.0 $66,070 - $86,310
-210 Reduced 11.67%
1,590 $607,000
Q4 2020

Feb 11, 2021

SELL
$246.9 - $321.87 $38,763 - $50,533
-157 Reduced 8.02%
1,800 $572,000
Q3 2020

Nov 12, 2020

SELL
$232.22 - $282.96 $20,899 - $25,466
-90 Reduced 4.4%
1,957 $485,000
Q2 2020

Aug 13, 2020

SELL
$185.43 - $279.56 $297,058 - $447,855
-1,602 Reduced 43.9%
2,047 $541,000
Q1 2020

May 08, 2020

SELL
$161.17 - $221.51 $78,006 - $107,210
-484 Reduced 11.71%
3,649 $692,000
Q4 2019

Feb 11, 2020

SELL
$189.68 - $222.09 $56,904 - $66,627
-300 Reduced 6.77%
4,133 $908,000
Q3 2019

Oct 24, 2019

SELL
$183.56 - $216.72 $133,081 - $157,122
-725 Reduced 14.06%
4,433 $868,000
Q2 2019

Aug 15, 2019

SELL
$188.72 - $215.43 $145,314 - $165,881
-770 Reduced 12.99%
5,158 $1.08 Million
Q1 2019

May 15, 2019

SELL
$136.09 - $200.44 $538,235 - $792,740
-3,955 Reduced 40.02%
5,928 $1.18 Million
Q4 2018

Feb 15, 2019

SELL
$132.75 - $203.8 $138,458 - $212,563
-1,043 Reduced 9.55%
9,883 $1.43 Million
Q3 2018

Nov 15, 2018

SELL
$147.44 - $204.11 $2.89 Million - $4 Million
-19,616 Reduced 64.23%
10,926 $2.23 Million
Q2 2018

Aug 14, 2018

SELL
$144.9 - $165.58 $161,853 - $184,952
-1,117 Reduced 3.53%
30,542 $4.52 Million
Q1 2018

May 15, 2018

SELL
$131.46 - $151.04 $237,811 - $273,231
-1,809 Reduced 5.41%
31,659 $4.78 Million
Q4 2017

Feb 15, 2018

SELL
$121.17 - $134.75 $223,437 - $248,479
-1,844 Reduced 5.22%
33,468 $4.34 Million
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $4.01 Million - $4.37 Million
35,312
35,312 $4.27 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.86B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.